Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;17(6):401.
doi: 10.1038/nri.2017.46. Epub 2017 May 8.

Immunosuppressive cell death in cancer

Jiajie Hou  1 , Tim F Greten  2 , Qiang Xia  1
Affiliations
Comment

Immunosuppressive cell death in cancer

Jiajie Hou et al. Nat Rev Immunol. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

The authors declare no competing interests.

Comment in

  • Reply: Immunosuppressive cell death in cancer.
    Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Galluzzi L, et al. Nat Rev Immunol. 2017 Jun;17(6):402. doi: 10.1038/nri.2017.48. Epub 2017 May 8. Nat Rev Immunol. 2017. PMID: 28480896 No abstract available.

Comment on

References

    1. Galluzzi L, Buque A, Kepp O, Zitvogel L & Kroemer G Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol 17, 97–111 (2017). - PubMed
    1. Richards CH, Mohammed Z, Qayyum T, Horgan PG & McMillan DC The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol. 7, 1223–1235 (2011). - PubMed
    1. Di Paolo NC & Shayakhmetov DM Interleukin 1α and the inflammatory process. Nat. Immunol 17, 906–913 (2016). - PMC - PubMed
    1. Hong DS et al. MABp1, a first‑in‑class true human antibody targeting interleukin‑1α in refractory cancers: an open‑label, phase 1 dose‑escalation and expansion study. Lancet Oncol. 15, 656–666 (2014). - PubMed
    1. Kang R, Zhang Q, Zeh HJ III, Lotze MT & Tang D HMGB1 in cancer: good, bad, or both? Clin. Cancer Res. 19, 4046–4057 (2013). - PMC - PubMed

Publication types

Substances